Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-05-04
2009-02-17
Saidha, Tekchand (Department: 1652)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S359000
Reexamination Certificate
active
07491693
ABSTRACT:
The present invention relates to a method for the prophylaxis and/or treatment of stroke and other ischemic injury, wherein HDL is administered to a subject in need thereof, particularly by intravenous infusion.
REFERENCES:
patent: 5780592 (1998-07-01), Mullner et al.
patent: WO 01/03705 (2001-01-01), None
patent: WO 01/13939 (2001-03-01), None
patent: WO 01/38395 (2001-05-01), None
Excerpt from MacQuarie Australia's National Dictionary; 2 pages, 1998.
Excerpt from Stedman's Medical Dictionary; pp. 924, 2000.
Excerpt from Black's Medical Dictionary; pp. 497, 1984.
Excerpt from Gould Medical Dictionary; pp. 798, 1972.
Orekhov, A.N. et al.; “Artificial HDL as an anti-atherosclerotic drug;” The Lancet; Nov. 17, 1984; pp. 1149-1150.
Dansky, Hayes M. et al.; “High-Density Lipoprotein and Plaque Regression: The Good Cholesterol Gets Even Better;” Circulation, Journal of the American Heart Association; 1999; vol. 100; pp. 1762-1763.
Badimon, J.J. et al.; “Regression of Atherosclerotic Lesions by High Density Lipoprotein Plasma Fraction in the Cholesterol-fed Rabbit;” Journal of Clinical Investigation; Apr. 1990; vol. 85; pp. 1234-1241.
Cockerill et al. “High-density lipoproteins rescue end-stage organ failure in a rat model of haemorraghic shock,”J. Submicroscopic Cyt. Path. 32(3): 353, 2000.
Klimov, et al., “Effect of high density lipoproteins on permeability of rabbit aorta to low density lipoproteins,”Atherosclerosis, 1985, 55(2):217-23.
Lerch, et al., “Reconstituted high density lipoprotein (rHDL) modulates platelet activity in vitro and ex vivo,”Thromb Haemost. 1998, 80(2):316-20.
Hubsch Alphonse
Lang Markus G.
CSL Behring AG
Foley & Lardner LLP
McCaslin R. Brian
Saidha Tekchand
LandOfFree
HDL for the treatment of stroke and other ischemic conditions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HDL for the treatment of stroke and other ischemic conditions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HDL for the treatment of stroke and other ischemic conditions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4063438